Orion

Orion EPS

The Earnings per Share (EPS) of Orion (271560.KS) as of Oct 15, 2026 is 9,681.68 KRW. In the previous year, Earnings per Share (EPS) was 13,271.15 KRW — a change of -27.05% (lower).

EPS

9,681.68KRW

YoY

-27.05%

Last updated:

Earnings per Share (EPS) of Orion is 2025 9,681.68 KRW. Earnings per Share (EPS) of Orion was 2024 13,271.15 KRW. It decreases by -27.05% lower compared to the previous year.

The Orion EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
6,519.41 KRW
Jan 1, 2022
9,925.71 KRW
Jan 1, 2023
9,528.41 KRW
Jan 1, 2024
13,271.15 KRW
Jan 1, 2025
9,681.68 KRW
Jan 1, 2026 (e)
11,974.33 KRW
Jan 1, 2027 (e)
13,404.28 KRW
Jan 1, 2028 (e)
14,558.45 KRW
The Orion EPS history
YEAREPSYoY
est14,558.45KRW+8.61%
est13,404.28KRW+11.94%
est11,974.33KRW+23.68%
9,681.68KRW-27.05%
13,271.15KRW+39.28%
9,528.41KRW-4.00%
9,925.71KRW+52.25%
6,519.41KRW-3.69%
6,769.40KRW+24.12%
5,453.73KRW+54.14%
3,538.18KRW+632.24%
483.20KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Orion Stock analysis

What does Orion do? Orion Corp is a Finnish company that operates in the pharmaceutical industry. The company was founded in 1917 and is headquartered in Espoo, Finland. Orion Corp specializes in the development, manufacturing, and marketing of medications, as well as the diagnosis and treatment of diseases. As one of the leading pharmaceutical companies in Finland, Orion Corp is dedicated to researching and developing medications and medical devices to help doctors and their patients worldwide improve their quality of life. Orion Corp's business model focuses on selling prescription and over-the-counter medications, as well as manufacturing generic medications. Additionally, the company is involved in the diagnosis and treatment of diseases such as Parkinson's, cancer, and asthma. The company's main business is centered around three main divisions: pharmaceuticals, diagnostics, and animal health. Within these divisions, Orion Corp has various business areas. In the pharmaceutical division, the focus is on developing medications to combat Parkinson's, cancer, and asthma. The company has a strong product range of Parkinson's treatments that can alleviate symptoms and slow the progression of the disease. Furthermore, the company is involved in the development of cancer medications that can inhibit the growth of cancer cells. Orion Corp is also a key player in asthma treatment. The company produces medications that expand the airways and make breathing easier. In the diagnostics division, Orion Corp's main business is the development and manufacturing of diagnostic devices for diseases such as lung cancer and asthma, as well as products for monitoring blood sugar and cholesterol. Animal health is another important business area for Orion Corp. The company manufactures medications and accessories for animal health and offers a variety of products to veterinarians and breeders. These include, for example, animal vaccines or hormone preparations to increase fertility in animals. Orion's production facilities are located in six countries, including Finland, Germany, France, Russia, the USA, and India. Production within the company primarily takes place in Finland. In addition to manufacturing medications and medical devices, Orion Corp is also a leading producer and developer of raw materials and intermediates for pharmaceutical applications worldwide. In summary, Orion Corp offers a wide range of products and services in the health and animal health fields using the latest scientific knowledge and technologies. The company remains committed to continuously expanding its product and service portfolio and providing patients worldwide with high-quality and effective medications that positively impact their lives. Orion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orion stock

Earnings per Share (EPS) of Orion is 9,681.68 KRW in 2025.

Earnings per Share (EPS) of Orion changed from 13,271.15 KRW to 9,681.68 KRW, representing a -27.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Orion since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Orion

All Key Metrics — Orion